National Cancer Institute Notice of Meeting, 39884 [2011-17075]
Download as PDF
39884
Federal Register / Vol. 76, No. 130 / Thursday, July 7, 2011 / Notices
appropriate endpoints for informative
clinical trials, the role and effect of
tympanocentesis (drainage of fluid from
the middle chamber of the ear) in
clinical trials, and the feasibility and
acceptability of different kinds of
clinical trial designs including
superiority trial designs, the data
available that might scientifically
support feasible non-inferiority trial
designs, and what additional data may
be useful to scientifically support noninferiority trial designs.
The Agency encourages individuals,
patient advocates, industry, consumer
groups, health care professionals,
researchers, and other interested
persons to attend this public workshop.
Transcripts: Please be advised that as
soon as a transcript is available, it will
be accessible at https://
www.regulations.gov. It may be viewed
at the Division of Dockets Management
(HFA–305), Food and Drug
Administration, 5630 Fishers Lane, Rm.
1061, Rockville, MD. A transcript will
also be available in either hardcopy or
on CD–ROM, after submission of a
Freedom of Information request. Written
requests are to be sent to Division of
Freedom of Information (ELEM–1029),
Food and Drug Administration, 12420
Parklawn Dr., Element Bldg., Rockville,
MD 20857. Transcripts will also be
available on the Internet https://
www.fda.gov/Drugs/NewsEvents/
ucm205809.htm approximately 45 days
after the workshop.
Dated: June 30, 2011.
Leslie Kux,
Acting Assistant Commissioner for Policy.
Name of Committee: National Cancer
Institute Board of Scientific Advisors;
caBIG® Oversight Ad hoc Subcommittee.
Date: July 25, 2011.
Time: 12 p.m. to 4 p.m.
Agenda: Evaluation of Scientific Merit of
caBIG® program, ongoing and planned
initiatives.
Place: Hilton Chicago O’Hare, Hilton
Chicago O’Hare International Airport,
Terminal 3, Access Road 5, Room 2051,
Chicago, IL 60666.
Contact Person: John Czajkowski, MPA,
Deputy Director for Management, Office of
the Director, National Cancer Institute,
National Institutes of Health, 31 Center Drive,
Rm. 11A48, Bethesda, MD 20892, 301–435–
2455, john.czajkowski@nih.gov.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
Information is also available on the
Institute’s/Center’s home page: https://
deainfo.nci.nih.gov/advisory/bsa.htm, where
an agenda and any additional information for
the meeting will be posted when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.392, Cancer Construction;
93.393, Cancer Cause and Prevention
Research; 93.394, Cancer Detection and
Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology
Research; 93.397, Cancer Centers Support;
93.398, Cancer Research Manpower; 93.399,
Cancer Control, National Institutes of Health,
HHS)
Dated: June 30, 2011.
Jennifer S. Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2011–17075 Filed 7–6–11; 8:45 am]
Name of Committee: National Institute of
Mental Health Special Emphasis Panel;
Fellowships and Dissertation Grants.
Date: July 20, 2011.
Time: 1:30 p.m. to 2:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Neuroscience Center, 6001 Executive
Boulevard, Rockville, MD 20852, (Telephone
Conference Call)
Contact Person: David W Miller, PhD,
Scientific Review Officer, Division of
Extramural Activities, National Institute of
Mental Health, NIH, Neuroscience Center,
6001 Executive BLVD, Room 6140, MSC
9608, Bethesda, MD 20892–9608, 301–443–
9734, millerda@mail.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.242, Mental Health Research
Grants; 93.281, Scientist Development
Award, Scientist Development Award for
Clinicians, and Research Scientist Award;
93.282, Mental Health National Research
Service Awards for Research Training,
National Institutes of Health, HHS)
Dated: June 30, 2011.
Jennifer S. Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2011–17073 Filed 7–6–11; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HOMELAND
SECURITY
Aviation Security Advisory Committee
BILLING CODE 4140–01–P
AGENCY:
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
ACTION:
Transportation Security
Administration, DHS.
[FR Doc. 2011–16962 Filed 7–6–11; 8:45 am]
BILLING CODE 4160–01–P
National Institutes of Health
National Institutes of Health
National Institute of Mental Health
Notice of Closed Meeting
National Cancer Institute Notice of
Meeting
sroberts on DSK5SPTVN1PROD with NOTICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Pursuant to section 10(a) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of a meeting of the
National Cancer Institute Board of
Scientific Advisors.
The meeting will be open to the
public, with attendance limited to space
available. Individuals who plan to
attend and need special assistance, such
as sign language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
VerDate Mar<15>2010
16:26 Jul 06, 2011
Jkt 223001
PO 00000
Frm 00074
Fmt 4703
Sfmt 4703
Committee Management; Notice
of Federal Advisory Committee ReEstablishment.
The Transportation Security
Administration (TSA) announces the reestablishment of the Aviation Security
Advisory Committee (ASAC). The
Secretary of Homeland Security has
determined that the re-establishment of
ASAC is necessary and is in the public
interest in connection with the
performance of duties of TSA. This
determination follows consultation with
the Committee Management Secretariat,
General Services Administration.
SUMMARY:
FOR FURTHER INFORMATION CONTACT:
Dean Walter, ASAC Designated Federal
Official, Transportation Security
Administration (TSA–28), 601 12th St.
South, Arlington, VA 20598–4028,
Dean.Walter@dhs.gov, 571–227–2645.
SUPPLEMENTARY INFORMATION:
E:\FR\FM\07JYN1.SGM
07JYN1
Agencies
[Federal Register Volume 76, Number 130 (Thursday, July 7, 2011)]
[Notices]
[Page 39884]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2011-17075]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Cancer Institute Notice of Meeting
Pursuant to section 10(a) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of a meeting of the
National Cancer Institute Board of Scientific Advisors.
The meeting will be open to the public, with attendance limited to
space available. Individuals who plan to attend and need special
assistance, such as sign language interpretation or other reasonable
accommodations, should notify the Contact Person listed below in
advance of the meeting.
Name of Committee: National Cancer Institute Board of Scientific
Advisors; caBIG[reg] Oversight Ad hoc Subcommittee.
Date: July 25, 2011.
Time: 12 p.m. to 4 p.m.
Agenda: Evaluation of Scientific Merit of caBIG[reg] program,
ongoing and planned initiatives.
Place: Hilton Chicago O'Hare, Hilton Chicago O'Hare
International Airport, Terminal 3, Access Road 5, Room 2051,
Chicago, IL 60666.
Contact Person: John Czajkowski, MPA, Deputy Director for
Management, Office of the Director, National Cancer Institute,
National Institutes of Health, 31 Center Drive, Rm. 11A48, Bethesda,
MD 20892, 301-435-2455, john.czajkowski@nih.gov.
Any interested person may file written comments with the
committee by forwarding the statement to the Contact Person listed
on this notice. The statement should include the name, address,
telephone number and when applicable, the business or professional
affiliation of the interested person.
Information is also available on the Institute's/Center's home
page: https://deainfo.nci.nih.gov/advisory/bsa.htm, where an agenda
and any additional information for the meeting will be posted when
available.
(Catalogue of Federal Domestic Assistance Program Nos. 93.392,
Cancer Construction; 93.393, Cancer Cause and Prevention Research;
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer
Control, National Institutes of Health, HHS)
Dated: June 30, 2011.
Jennifer S. Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 2011-17075 Filed 7-6-11; 8:45 am]
BILLING CODE 4140-01-P